Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants

ABSTRACT Neutralizing antibody titers and binding antibody levels are considered correlates of protection against severe SARS-CoV-2 infection. The clinical utility of serology should be reevaluated in light of the emergence of escape variants, as commercial antibody-binding assays have not been adap...

Повний опис

Бібліографічні деталі

Автори:	Léa Dépéry, Isabelle Bally, Axelle Amen, Benjamin Némoz, Marlyse Buisson, Laurence Grossi, Aurélie Truffot, Raphaële Germi, Delphine Guilligay, Mélanie Veloso, Antoine Vilotitch, Olivier Epaulard, Patrice Morand, Winfried Weissenhorn, Pascal Poignard, Julien Lupo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	American Society for Microbiology 2025-01-01
Серія:	Microbiology Spectrum
Предмети:	SARS-CoV-2 serology neutralizing antibodies Omicron COVID
Онлайн доступ:	https://journals.asm.org/doi/10.1128/spectrum.01568-24
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!